November 19 2009

The National Prescribing Service is once again hosting the National Medicines Symposium (NMS) and is calling for abstracts from across the health sector.

Now in its sixth biennium, NMS 2010 will be held at the Melbourne Conference and Exhibition Centre from 26-28 May 2010.

“The theme of NMS 2010 is Medicines in people’s live, which enables us to address quality use of medicines in the wider context of changes within the health sector, including reforms and new prescribers,” NPS CEO, Dr Lynn Weekes said.

“The National Medicines Symposium is unique in bringing together everyone involved with medicines use, including primary healthcare providers, specialists, policy makers, academics and international experts. It transcends industry silos and provides those working at the coalface the opportunity to share expertise, experience and opinion, and benefit from discussion with industry peers,” Dr Weekes said.

NMS 2010 will include a number of panel sessions with key opinion leaders addressing political issues, as well as in-depth clinical presentations from leading clinicians and academics.

Health professionals, academics, researchers and policy analysts are invited to submit abstracts for oral presentation or poster display during NMS. Topics may cover clinical practice, education, research, complementary medicines, leadership, policy, innovations or future directions for quality use of medicines and must address the theme, Medicine in people’s lives.

“A key component of NMS has always been the high-quality abstracts presented by national and international health professionals and medicines experts. This allows those working at the forefront of medicines use the opportunity to showcase their work and gives other delegates deeper insight to some of the issues,” Dr Weekes said.

Full details of NMS including registration and abstract requirements are available at www.nms2010.org.au

ENDS

The National Prescribing Service Limited (NPS) is an independent, not-for-profit organisation for quality use of medicines funded by the Australian Government Department of Health and Ageing.